Delisting Determination, The Nasdaq Stock Market, LLC, May 16, 2024,
NeuBase Therapeutics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of NeuBase Therapeutics, Inc., effective
at the opening of the trading session on May 28, 2024.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rule 5550(a)(2).
The Company was notified of the Staff determination on May 2,
2024. The Company did not appeal the Staff determination to the
Hearings Panel. The Company securities were suspended on May 13,
2024. The Staff determination to delist the Company securities
became final on May 13, 2024.